All Stories

  1. Adjuvant Dapagliflozin in Kidney Transplant Recipients with Diabetes and Heart Failure—An Observational Exploratory Study
  2. Managing peritoneal dialysis catheter after kidney transplant
  3. Real-World Outcomes of SGLT2 Inhibitors in Kidney Transplant Recipients with Post-Transplant Diabetes Mellitus: An Effectiveness and Safety Analysis
  4. GLP-1 receptor agonists in kidney transplant recipients with post-transplant diabetes: efficacy and safety outcomes from a retrospective cohort study
  5. Living Kidney Donor Perceptions About Organ Donation: Who are They, and How Do They Feel About the Process?
  6. Psychological Outcomes in a Cohort of Portuguese Living Kidney Donors
  7. Insights Into Peritoneal Dialysis Outcomes: An Approach Using Competing Risks Analysis
  8. Preoperative mapping and multidisciplinary team are the key to success of arteriovenous access for hemodialysis
  9. Agonistas do Receptor de Peptídeo Semelhante ao Glucagon-1 em Transplantados Renais - Estudo Retrospectivo de um Centro Hospitalar
  10. Glucagon-like Peptide-1 Receptor Agonists in Kidney Transplant Recipients – A Retrospective Single Center Study
  11. Comunicação na Prática Clínica, a Perspetiva dos Doentes com Cancro: Tradução do Questionário PACE (Patient Assessment Of Cancer Communication Experiences) para Português
  12. Predict mortality in elderly ESKD patients
  13. Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients
  14. Adenovirus infection—A rare cause of interstitial nephritis in kidney transplant
  15. The association between 25(OH)D levels, frailty status and obesity indices in older adults
  16. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
  17. Psychopathological dimensions in subjects with hereditary ATTR V30M amyloidosis and their relation with life events due to the disease
  18. Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study
  19. ESPEN diagnostic criteria for malnutrition – A validation study in hospitalized patients
  20. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
  21. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study
  22. End-stage renal disease versus death in a Portuguese cohort of elderly patients: an approach using competing event analysis
  23. Comparison of Jamar and Bodygrip Dynamometers for Handgrip Strength Measurement
  24. Triceps skinfold compressibility in hospitalized patients
  25. Incorporating Scoring Risk Models for Care Planning of the Elderly with Chronic Kidney Disease
  26. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation
  27. Effects of Posture and Body Mass Index on Body Girth Assessment
  28. Financial impact of sarcopenia on hospitalization costs
  29. Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments
  30. Sarcopenia and length of hospital stay
  31. Sarcopenia among hospitalized patients – A cross-sectional study
  32. A triple-biomarker approach for the detection of delayed graft function after kidney transplantation using serum creatinine, cystatin C, and malondialdehyde
  33. Impact ofde novodonor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation
  34. Usefulness of Six Diagnostic and Screening Measures for Undernutrition in Predicting Length of Hospital Stay: A Comparative Analysis
  35. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
  36. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis
  37. Leptin and Adiponectin During the First Week After Kidney Transplantation: Biomarkers of Graft Dysfunction?
  38. Health-related quality of life may improve after transplantation in pancreas-kidney recipients
  39. Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
  40. Comparative analysis of undernutrition screening and diagnostic tools as predictors of hospitalisation costs
  41. Handgrip strength measurement as a predictor of hospitalization costs
  42. Adipokines in Peritoneal Dialysis: Relevant Clinical Impact According to Body Composition
  43. Handgrip strength cutoff values for undernutrition screening at hospital admission
  44. Oxidative Stress in Kidney Transplantation
  45. Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?
  46. Posttransplant Allosensitization in Low Immunological Risk Kidney and Kidney-Pancreas Graft Recipients
  47. Handgrip Strength and Associated Factors in Hospitalized Patients
  48. Hand length as an alternative measurement of height
  49. Kidney Transplantation in Type 2 Diabetic Patients: A Matched Survival Analysis
  50. Cardiovascular Risk Factors and Events in Pancreas-Kidney Transplants
  51. Noncutaneous Neoplasms After Kidney Transplantation: Analysis at Single Center
  52. Pregnancy After Kidney Transplantation: Graft, Mother, and Newborn Complications
  53. A Comparison Between Serum Creatinine and Cystatin C-Based Equations for Estimation of Graft Function
  54. Advantages of Kidney Transplant Precocity in Graft Long-Term Survival
  55. Hyperuricemia in Adult Renal Allograft Recipients: Prevalence and Predictors
  56. Over Ten-Year Kidney Graft Survival Determinants
  57. First-Year Renal Function Predicts Long-Term Renal Allograft Loss
  58. Impact of Pediatric Kidney Transplantation on Long-Term Professional and Social Outcomes
  59. Steroid Withdrawal in Simultaneous Pancreas-Kidney Transplantation: A 7-Year Report
  60. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M
  61. Impact Assessment in Living Kidney Donation: Psychosocial Aspects in the Donor
  62. Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M
  63. Low Erythropoietin Production in Familial Amyloidosis TTR V30M Is Not Related with Renal Congophilic Amyloid Deposition
  64. The Influence of HLA Mismatches and Immunosuppression on Kidney Graft Survival: An Analysis of More Than 1300 Patients
  65. Peritoneal Membrane Evaluation in Routine Clinical Practice
  66. Liver transplantation and anemia in familial amyloidosis ATTR V30M
  67. Impact of Hepatitis C Virus on Renal Transplantation: Association With Poor Survival
  68. Renal Transplantation in Patients Over 60 Years of Age: A Single-Center Experience
  69. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation
  70. Immunosuppression With Antithymocyte Globulin in Renal Transplantation: Better Long-Term Graft Survival
  71. Impact of Homocysteinemia on Long-Term Renal Transplant Survival
  72. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry
  73. Kidney and anemia in familial amyloidosis type I
  74. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors
  75. Kinetic modeling studies of ethylene polymerization reactions using supported chromium catalysts
  76. Homocysteine levels in pediatric renal transplant recipients
  77. Lipoprotein(A) in renal transplant recipients
  78. Hyperhomocysteinemia in renal transplantation: preliminary results
  79. Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil